• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 4 filed by Director Loughran Barbara

    4/10/25 4:40:38 PM ET
    $AMTM
    Get the next $AMTM alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    Loughran Barbara

    (Last) (First) (Middle)
    C/O AMENTUM HOLDINGS, INC.
    4800 WESTFIELDS BOULEVARD, SUITE 400

    (Street)
    CHANTILLY VA 20151

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    Amentum Holdings, Inc. [ AMTM ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    X Director 10% Owner
    Officer (give title below) Other (specify below)
    3. Date of Earliest Transaction (Month/Day/Year)
    04/08/2025
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Restricted Stock Units (1) 04/08/2025 A 11,564 (2) (2) Common Stock 11,564 $0 11,564 D
    Explanation of Responses:
    1. Each restricted stock unit represents a contingent right to receive one share of AMTM common stock.
    2. The restricted stock units shall vest on the date of the next annual meeting of stockholders of the Issuer.
    Remarks:
    /s/ Paul W. Cobb, Jr. Attorney-in-fact 04/10/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $AMTM alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $AMTM

    DatePrice TargetRatingAnalyst
    6/10/2025$24.00Neutral
    BofA Securities
    5/12/2025$30.00Mkt Outperform
    Citizens JMP
    4/16/2025$19.00Underweight
    Morgan Stanley
    4/15/2025$30.00Buy
    BTIG Research
    3/20/2025$21.00Neutral
    Goldman
    2/7/2025$25.00Neutral
    Cantor Fitzgerald
    1/10/2025$24.00Sector Perform
    RBC Capital Mkts
    11/21/2024$30.00Outperform
    Raymond James
    More analyst ratings

    $AMTM
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Amentum Announces Award for the Management and Operations of Canadian Nuclear Laboratories

      Amentum (NYSE:AMTM), a global leader in advanced engineering and innovative technology solutions, announced the award of a significant new contract from Atomic Energy of Canada Limited (AECL) to provide operations and management solutions for Canadian Nuclear Laboratories (CNL). Under this contract, Amentum will help advance nuclear science, technology, and innovation across Canada. "This contract award reflects our deep expertise in nuclear operations and environmental remediation, and our commitment to delivering safe, reliable, and innovative solutions that serve the best interests of Canada," said Mark Whitney, Amentum's Energy and Environment president. "We will pursue valuable colla

      6/12/25 10:05:00 AM ET
      $AMTM
    • Amentum Reports Second Quarter Fiscal Year 2025 Results

      Revenues of $3.5 billion, 1% growth on a pro forma basis Net Income of $4 million; Adjusted EBITDA of $268 million Diluted Earnings Per Share of $0.02; Adjusted Diluted Earnings Per Share of $0.53 Operating Cash Flow of $57 million; Free Cash Flow of $53 million Backlog of $45 billion; 1.0x YTD Book-to-Bill Amentum Holdings, Inc. ("Amentum" or the "Company") (NYSE:AMTM), a leading advanced engineering and technology company, today announced results for the second quarter ended March 28, 2025 and updated its outlook for fiscal year 2025, reaffirming the mid-points of prior guidance. "Amentum delivered solid results this quarter, underscoring the strength of our mission-focused portfoli

      5/6/25 4:30:00 PM ET
      $AMTM
    • Jacobs Reports Strong Fiscal Second Quarter 2025 Results

      Backlog Grows by 20% Year-Over-Year with TTM Book-to-Bill Ratio of 1.3x Repurchased $351 Million of Jacobs Shares During Q2 and $552 Million in First Half of FY25 Exited Company's Retained Stake in AMTM and Announced May 30th Distribution of Remaining Shares Reaffirming FY 2025 Guidance DALLAS, May 6, 2025 /PRNewswire/ -- Jacobs Solutions Inc. (NYSE:J) today announced its financial results for the fiscal second quarter ended March 28, 2025. Q2 2025 Highlights1: Gross revenue of $2.9 billion grew 2.2% y/y; adjusted net revenue2 up 3.1% y/yRevenue and profit adversely impacted by a reserve following an interim ruling against a consolidated JV in Q2 2025GAAP net earnings of $11.2 million; adjus

      5/6/25 6:45:00 AM ET
      $AMTM
      $J
      Military/Government/Technical
      Industrials

    $AMTM
    SEC Filings

    See more
    • Amendment: SEC Form SCHEDULE 13G/A filed by Amentum Holdings Inc.

      SCHEDULE 13G/A - Amentum Holdings, Inc. (0002011286) (Subject)

      5/9/25 1:39:55 PM ET
      $AMTM
    • SEC Form 10-Q filed by Amentum Holdings Inc.

      10-Q - Amentum Holdings, Inc. (0002011286) (Filer)

      5/7/25 4:37:47 PM ET
      $AMTM
    • Amentum Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - Amentum Holdings, Inc. (0002011286) (Filer)

      5/6/25 4:38:12 PM ET
      $AMTM